Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

1,525 recalls · Class III, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 20262025202420232022 All years
Cause Sterility / contaminationNitrosamine impurityChemical / undeclaredParticulate / foreign matterLabeling / mix-upcGMP deviationMicrobial contamination All causes
Class III · Low risk

Gatifloxacin Ophthalmic Solution

Failed Stability Specifications: Out-of-specification results observed in a water loss test that might affect the assay content and alter drug concentration.

Terminated Stability / shelf life Lupin Pharmaceuticals Inc. NDC 68180-435-01 D-0091-2022
Class III · Low risk

AERO Tab PAIN RELIEVER

Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.

Terminated Stability / shelf life Ultra Seal Corporation D-0073-2022
Class III · Low risk

Vica-Cet BACK PAIN RELIEF

Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.

Terminated Stability / shelf life Ultra Seal Corporation D-0071-2022
Class III · Low risk

PainAway II

Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.

Terminated Stability / shelf life Ultra Seal Corporation D-0070-2022
Class III · Low risk

Cetirizine hydrochloride

Labeling: Not Elsewhere classified: Product was relabeled as 90 tablet count product although it was a manufacturer in a box with 30 tablet count tablets.

Terminated Labeling / mix-up A-S Medication Solutions LLC. D-0096-2022
Class III · Low risk

Hydroquinone

Subpotency: one product for active ingredient assay and another one for preservative assay

Terminated Wrong potency / content Monarch PCM, LLC NDC 69367-174-01 D-0818-2021
Class III · Low risk

Sodium Sulfacetamide

Subpotency: one product for active ingredient assay and another one for preservative assay

Terminated Wrong potency / content Monarch PCM, LLC NDC 42808-103-06 D-0817-2021
Class III · Low risk

Avicel

Out of specification results for conductivity.

Terminated Failed specification DuPont Nutrition USA, Inc D-0728-2021
Class III · Low risk

Lidocaine Ointment USP

Failed Viscosity Specifications: lot does not meet specification for Viscosity, which was determined through routine testing.

Terminated Failed specification Teligent Pharma, Inc. NDC 52565-008-14 D-0785-2021

Recalls by year